Professor Daniel Offen, Ph.D.
CHIEF SCIENTIFIC ADVISOR
Professor Offen, who enjoys an internationally recognized reputation in neuroscience research, is a scientific founder of BrainStorm Cell Therapeutics together with Professor Eldad Melamed.
Prof. Offen continues to be a key academic collaborator with BrainStorm on multiple preclinical projects. Since 1993 he has been head of the Neuroscience Laboratory at Tel Aviv University School of Medicine. He has lectured extensively, both at Tel Aviv University and international scientific conferences, and has supervised many PhD students. Dr. Offen has published over 100 original scientific papers and several patents. Dr. Offen is a member of the Scientific Committee of the Israel Society for Neuroscience.
Professor Eldad Melamed, M.D.
FOUNDING CHIEF MEDICAL ADVISOR
Professor Melamed, with Professor Offen, together developed the NurOwn technology. He served as the Chief Medical Advisor to BrainStorm since its inception, until his passing in September 2015.
Professor Melamed was a world-renowned expert in the field of neurodegenerative diseases, particularly on Parkinson’s disease. Prof. Melamed served as head of the Neurology Department at the Rabin Medical Center and Tel Aviv University from 1987-2015. Throughout his career, he specialized in neurology, holding senior positions at the Hebrew University (Jerusalem), Bispebjerg Hospital (Copenhagen), National Hospital (London) and at the Laboratory of Neuroendocrine Regulation (Massachusetts). He was a past president of the Israel Neurological Association and former director of the National Parkinson Foundation (USA). Prof. Melamed was a member of the Scientific Committee of the Michael J Fox Foundation for Parkinson’s Research.